Conclusions
diabetic and non-diabetic populations, diabetes
DIABETES
Among people with diabetes taking daily low-dose aspirin versus placebo, the reduction in U-TXM was similar to that seen in other diabetic and non-diabetic populations. There was no evidence of substantive deterioration in suppression over 24 h and the aspirin regimen in ASCEND resulted in statistically significant cardioprotection [